Toronto Stock Exchange, Marvel Biosciences Corp., The View from the C-Suite

Core Viewpoint - Marvel Biosciences Corp. is focused on the discovery and development of synthetic derivative compounds from known drugs, targeting various neurological and non-neurological diseases [3] Company Overview - Marvel Biosciences Corp. is a life sciences company listed on the TSX Venture Exchange under the ticker MRVL [3] - The company has developed several new patented and patentable chemical entities that inhibit the A2a adenosine receptor [3] - Applications of these compounds include treatment for neurological diseases such as depression, anxiety, Alzheimer's, ADHD, and addiction, as well as non-alcoholic steatohepatitis liver fibrosis [3]